Sun Pharma gets U.S. nod for blood pressure drug

BANGALORE, June 19 (Reuters) - India's Sun Pharmaceutical Industries Ltd (SUN.BO) said on Friday it had received approval from the U.S. Food and Drug Administration to launch generic version of Pfizer's (PFE.N) blood pressure drug Accupril.

The drug has annual sales of about $45 million in the United States, the Indian drug maker said in a statement. (Reporting by Sumeet Chatterjee)